GE HealthCare Technologies Inc.

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
80.28 ^USD	+0.43%		+4.18%	+3.83%

Jul. 10	Goldman Sachs Adjusts Price Target on GE HealthCare Technologies to $83 From $87	MT
Jul. 10	3M CFO Patolawala to leave company at end of July	RE

GE Healthcare Technologies Inc. Provides Revenue Guidance for the Full Year 2023

January 10, 2023 at 06:30 am EST

GE HealthCare Technologies Inc. provided revenue guidance for the full year 2023. For the year, the company expected organic revenue growth in the range of 5% to 7% year over year.

Latest news about GE HealthCare Technologies Inc.

Goldman Sachs Adjusts Price Target on GE HealthCare Technologies to $83 From $87	Jul. 10	MT
3M CFO Patolawala to leave company at end of July	Jul. 10	RE
UBS Adjusts Price Target on GE HealthCare Technologies to $84 From $88, Maintains Neutral Rating	Jul. 02	MT
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Growth Index	Jun. 30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Value Index	Jun. 30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Index	Jun. 30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Growth Index	Jun. 30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Index	Jun. 30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Value Index	Jun. 30	CI
GE HealthCare Technologies Keeps Quarterly Dividend at $0.03 Per Share, Payable Aug. 15 to Shareholders of Record on July 19	Jun. 26	MT
GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024	Jun. 26	CI
GE HealthCare Partners With New Mexico Hospital to Install Allia IGS Pulse Electrophysiology Lab	Jun. 24	MT
GE HealthCare, MediView Report Clinical Use of OmnifyXR Interventional Suite	Jun. 20	MT
GE Healthcare and Mediview Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite That Aims to Transform the Practice of Interventional Radiology	Jun. 20	CI
GE HealthCare Reports Changes in Key Segments	Jun. 10	MT
GE Healthcare Technologies Inc. Announces Management Changes	Jun. 10	CI
Transcript : GE HealthCare Technologies Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:00 AM	Jun. 05
Nucleus RadioPharma, Inc. announced that it has received $66.099956 million in funding from a group of investors	Jun. 04	CI
GE HealthCare, Tampa General Hospital Expand Collaboration in Imaging, Ultrasound Technology	May. 30	MT
GE Healthcare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida	May. 30	CI
Goldman Sachs Initiates GE HealthCare Technologies With Neutral Rating, $87 Price Target	May. 30	MT
GE Healthcare Names Adam Holton as Chief People Officer	May. 29	CI
Some of the biggest splits in Corporate America	May. 23	RE
GE HealthCare Technologies Insider Sold Shares Worth $7,109,427, According to a Recent SEC Filing	May. 16	MT
Transcript : GE HealthCare Technologies Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:00 AM	May. 14

Chart GE HealthCare Technologies Inc.

Duration

Period

More charts

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-31 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for GE HealthCare Technologies Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

80.28 USD

Average target price

92.55 USD

Spread / Average Target

+15.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
GE HEALTHCARE TECHNOLOGIES INC.	+3.83%	36.65B
THERMO FISHER SCIENTIFIC	+3.26%	209B
DANAHER CORPORATION	+6.55%	183B
INTUITIVE SURGICAL, INC.	+31.66%	158B
BOSTON SCIENTIFIC CORPORATION	+34.32%	114B
SIEMENS HEALTHINEERS AG	+5.13%	67.29B
EDWARDS LIFESCIENCES CORPORATION	+19.33%	54.83B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	46.88B
AGILENT TECHNOLOGIES, INC.	-4.84%	38.58B
RESMED, INC.	+19.07%	30.09B

Other Advanced Medical Equipment & Technology